Christoph Thiemermann Selected Research

Inflammation

02/2008	Sphingosylphosphorylcholine reduces the organ injury/dysfunction and inflammation caused by endotoxemia in the rat.
02/2007	Glycogen synthase kinase 3beta as a target for the therapy of shock and inflammation.
01/2007	Lipoproteins in inflammation and sepsis. I. Basic science.
12/2005	Hydrogen sulfide and sulfite: novel mediators in the pathophysiology of shock and inflammation.
03/2005	Endogenous interleukin-6 enhances the renal injury, dysfunction, and inflammation caused by ischemia/reperfusion.
03/2005	Beneficial effects of PPAR-gamma ligands in ischemia-reperfusion injury, inflammation and shock.
10/2004	Noncleavable poly(ADP-ribose) polymerase-1 regulates the inflammation response in mice.
08/2004	Tempol reduces the activation of nuclear factor-kappaB in acute inflammation.
02/2004	Peptidoglycan of Staphylococcus aureus causes inflammation and organ injury in the rat.
01/2004	Rosiglitazone, a ligand of the peroxisome proliferator-activated receptor-gamma, reduces acute inflammation.
02/2003	Protein tyrosine kinase inhibitors as novel therapeutics for systemic inflammation, shock, and organ injury.
01/2003	Membrane-permeable radical scavengers (tempol) for shock, ischemia-reperfusion injury, and inflammation.
05/2002	The cyclopentenone prostaglandin 15-deoxy-Delta(12,14)-prostaglandin J(2) attenuates the development of acute and chronic inflammation.
01/2002	Pyrrolidine dithiocarbamate attenuates the development of acute and chronic inflammation.

Articles by Research Topic

Disease

20	Reperfusion Injury 10/2008 - 03/2002
14	Inflammation 02/2008 - 01/2002
13	Shock 02/2007 - 05/2002
11	Ischemia 09/2008 - 11/2002
9	Endotoxemia 09/2008 - 07/2002
6	Sepsis (Septicemia) 01/2007 - 11/2003
5	Septic Shock (Toxic Shock Syndrome) 02/2006 - 04/2003
4	Colitis 03/2006 - 04/2004
4	Hemorrhagic Shock 02/2005 - 09/2002
3	Arthritis (Polyarthritis) 07/2006 - 12/2003
3	Pancreatitis 05/2004 - 05/2002
2	Transient Ischemic Attack 09/2008 - 08/2006
2	Wounds and Injuries (Trauma) 09/2008 - 08/2003
2	Spinal Cord Injuries (Spinal Cord Injury) 07/2006 - 02/2005
2	Acute Kidney Failure (Acute Renal Failure) 12/2005 - 02/2004
2	Myocardial Ischemia (Ischemic Heart Diseases) 07/2004 - 05/2003
2	Multiple Organ Failure (MODS) 03/2004 - 10/2002
2	Myocardial Infarction 07/2002 - 07/2002
1	Anoxia (Hypoxia) 09/2008
1	Asthma (Bronchial Asthma) 09/2007
1	Hemorrhage 05/2006
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 12/2004
1	Heart Failure 07/2004
1	Myocardial Reperfusion Injury 07/2004
1	Tissue Adhesions 12/2003
1	Experimental Arthritis 10/2002

Drug/Important Bio-Agent (IBA)

17	PPAR gammaIBA 01/2007 - 07/2002
8	ErythropoietinIBA 01/2007 - 07/2004
7	Glycogen Synthase (Synthase I)IBA 09/2008 - 03/2006
6	LigandsIBA 03/2005 - 07/2002
5	rosiglitazone (Avandia)FDA Link 05/2004 - 09/2003
4	ZymosanIBA 01/2007 - 10/2002
4	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 02/2006 - 03/2002
3	Hydrogen Sulfide (Sulfide, Hydrogen)IBA 10/2008 - 10/2005
3	Simvastatin (Zocor)FDA LinkGeneric 08/2008 - 05/2003
3	Glycogen Synthase KinasesIBA 02/2007 - 01/2007
3	Nitric Oxide (Nitrogen Monoxide)FDA Link 02/2007 - 07/2002
3	Lipoproteins (Lipoprotein)IBA 01/2007 - 07/2003
3	PPAR alphaIBA 08/2006 - 07/2002
3	Collagen Type II (Type II Collagen)IBA 07/2006 - 12/2003
3	GW 274150IBA 01/2005 - 10/2002
3	9-deoxy-delta-9-prostaglandin D2IBA 12/2004 - 08/2003
3	5-aminoisoquinolinoneIBA 12/2004 - 11/2002
3	Caerulein (Ceruletide)IBA 05/2004 - 05/2002
2	2-chloro-5-nitrobenzanilideIBA 04/2006 - 08/2005
2	Interleukin-6 (Interleukin 6)IBA 03/2005 - 06/2002
2	Arachidonate 5-Lipoxygenase (5 Lipoxygenase)IBA 11/2004 - 08/2004
2	zileuton (Zyflo)FDA Link 11/2004 - 08/2004
2	tempolIBA 08/2004 - 01/2003
2	HDL LipoproteinsIBA 04/2004 - 03/2004
2	cyclopentenoneIBA 02/2004 - 05/2002
2	Peptidoglycan (Murein)IBA 02/2004 - 11/2003
2	pyrrolidine dithiocarbamic acidIBA 12/2003 - 01/2002
2	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 11/2003 - 02/2003
2	lipoteichoic acidIBA 11/2003 - 10/2002
2	Superoxide DismutaseIBA 04/2003 - 09/2002
2	CatalaseIBA 04/2003 - 09/2002
2	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 07/2002 - 07/2002
1	Cystathionine gamma-Lyase (Cysteine Desulfhydrase)IBA 10/2008
1	4- benzyl- 2- methyl- 1,2,4- thiadiazolidine- 3,5- dioneIBA 09/2008
1	sphingosine phosphorylcholineIBA 02/2008
1	Xanthine DehydrogenaseIBA 02/2007
1	lysophosphatidic acid (MOPA)IBA 01/2007
1	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 01/2007
1	CurcuminIBA 07/2006
1	Lysophosphatidylcholines (Lysophosphatidylcholine)IBA 07/2006
1	T 0070907IBA 04/2006
1	CatecholaminesIBA 02/2006
1	liver X receptorIBA 02/2006
1	glycogen synthase kinase 3 betaIBA 09/2005
1	E 64IBA 04/2005
1	PD 150606IBA 04/2005
1	CalpainIBA 04/2005
1	poly ADP-ribose glycohydrolaseIBA 03/2005
1	NADPH Oxidase (NAD(P)H oxidase)IBA 02/2005
1	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 02/2005
1	Poly Adenosine Diphosphate RiboseIBA 10/2004
1	NF-kappa B (NF-kB)IBA 07/2004
1	15-deoxy-delta(12,14)-prostaglandin J2IBA 02/2004
1	AG 127 (AG 126)IBA 11/2003
1	diadenosine tetraphosphateIBA 08/2003
1	Oxidopamine (6 Hydroxydopamine)IBA 08/2003
1	Clofibrate FDA Link 12/2002
1	calpain inhibitorsIBA 10/2002
1	1,3- dihydroxy- 4,4,5,5- tetramethyl- 2- (4- carboxyphenyl)tetrahydroimidazole (NOR 1)IBA 07/2002
1	Ribose (D-Ribose)IBA 05/2002
1	LigasesIBA 05/2002
1	Adenosine FDA LinkGeneric 05/2002

Therapy/Procedure

1	Investigational Therapies (Experimental Therapy) 09/2008
1	Resuscitation 05/2006
1	Therapeutics 02/2003